| Literature DB >> 26951836 |
Ali Roghanian1, Christopher Fraser2, Marianna Kleyman2, Jianzhu Chen3.
Abstract
Three recent studies, approaching the question from different angles and using different and/or overlapping models, provide compelling evidence for the involvement of tumor-infiltrating B cells in the initiation and progression of pancreatic ductal adenocarcinoma. These studies highlight the need for a better understanding of pancreatic tumor-immune system interactions and the immunologic mechanisms that promote or inhibit tumorigenesis, paving the way for better treatment strategies. ©2016 American Association for Cancer Research.Entities:
Mesh:
Year: 2016 PMID: 26951836 DOI: 10.1158/2159-8290.CD-16-0100
Source DB: PubMed Journal: Cancer Discov ISSN: 2159-8274 Impact factor: 39.397